Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)
Technical Analysis Report for NASDAQ stock CRSP Crispr Therapeutics. Dated: 31 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics
Crispr Therapeutics Opened at 48.54 and Closed at: 47.99, which is -0.94% of previous session's close. It moved within a range of 47.31 and 49.03
The session was a Bearish session with an average volume of 1036200, which is -33.23% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- There is some negative change in the mid term trend, but its too soon to jump onto conclusions.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 46.79 and resistance for tomorrow is 48.51
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 47.19, 46.39 resistance for tomorrow's hourly charts is 48.91, 49.83
10 Day SMA for Crispr Therapeutics (CRSP) is 47.43 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Crispr Therapeutics (CRSP) is 50 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Crispr Therapeutics (CRSP) is 52.17 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 51.65 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Crispr Therapeutics is 53.88 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Crispr Therapeutics is at 50 and 200 DMA is at 53.88, while 50 DMA and 100 DMA are at 52.17 and 51.65 respectively
Crispr Therapeutics (CRSP) moving average of 20 SMA is at 50 and 20 EMA is at 49.41
| Date | Closing Price | 20 SMA | 20 EMA |
| 31 Fri Jul | 47.99 | 50 | 49.41 |
| 30 Thu Jul | 48.44 | 50.69 | 49.56 |
| 29 Wed Jul | 47.64 | 51.27 | 49.68 |
| 28 Tue Jul | 47.55 | 51.67 | 49.89 |
| 27 Mon Jul | 46.73 | 52.02 | 50.14 |
| 24 Fri Jul | 46.54 | 52.5 | 50.5 |
Crispr Therapeutics (CRSP) moving average of 50 SMA is at 52.17 and 50 EMA is at 51.2
| Date | Closing Price | 50 SMA | 50 EMA |
| 31 Fri Jul | 47.99 | 52.17 | 51.2 |
| 30 Thu Jul | 48.44 | 52.18 | 51.33 |
| 29 Wed Jul | 47.64 | 52.17 | 51.45 |
| 28 Tue Jul | 47.55 | 52.18 | 51.61 |
| 27 Mon Jul | 46.73 | 52.2 | 51.78 |
| 24 Fri Jul | 46.54 | 52.28 | 51.99 |
Crispr Therapeutics (CRSP) moving average of 100 SMA is at 51.65 and 100 EMA is at 52.1
| Date | Closing Price | 100 SMA | 100 EMA |
| 31 Fri Jul | 47.99 | 51.65 | 52.1 |
| 30 Thu Jul | 48.44 | 51.7 | 52.18 |
| 29 Wed Jul | 47.64 | 51.8 | 52.26 |
| 28 Tue Jul | 47.55 | 51.89 | 52.35 |
| 27 Mon Jul | 46.73 | 51.99 | 52.45 |
| 24 Fri Jul | 46.54 | 52.12 | 52.57 |
Crispr Therapeutics (CRSP) moving average of 200 SMA is at 53.88 and 200 EMA is at 52.04
| Date | Closing Price | 200 SMA | 200 EMA |
| 31 Fri Jul | 47.99 | 53.88 | 52.04 |
| 30 Thu Jul | 48.44 | 53.99 | 52.08 |
| 29 Wed Jul | 47.64 | 54.1 | 52.12 |
| 28 Tue Jul | 47.55 | 54.2 | 52.17 |
| 27 Mon Jul | 46.73 | 54.33 | 52.22 |
| 24 Fri Jul | 46.54 | 54.47 | 52.28 |
Zai Lab has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Zai Lab, about 15.45% more returns!
Twist Bioscience has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Twist Bioscience, about 21.6% more returns!
Trupanion Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Trupanion Inc, about 11.57% more returns!
Crispr Therapeutics has performed better than Sutro Biopharma in short term. Holding Crispr Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Summit Therapeutics, about 3.02% more returns!
Riot Blockchain has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Riot Blockchain, about 16.35% more returns!
Uniqure N has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Uniqure N, about 26.39% more returns!
Ovid Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 0.74% more returns!
Omeros Corporation has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Omeros Corporation, about 35.65% more returns!
Crispr Therapeutics has performed better than Myriad Genetics in short term. Holding Crispr Therapeutics could be a better choice for now!
Ligand Pharmaceuticals has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Ligand Pharmaceuticals, about 11.05% more returns!
Acadia Healthcare has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 13.82% more returns!
Amphastar Pharmaceuticals has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Amphastar Pharmaceuticals, about 20.33% more returns!
Anixa Biosciences has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Anixa Biosciences, about 36.57% more returns!
Biolife Solutions has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Biolife Solutions, about 33.02% more returns!
Biomerica Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Biomerica Inc, about 7.66% more returns!
Crispr Therapeutics has performed better than Co Diagnostics in short term. Holding Crispr Therapeutics could be a better choice for now!
Icon Plc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Icon Plc, about 17.98% more returns!
Crispr Therapeutics has performed better than Jaguar Health in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics Technical analysis of indicators
Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.4 and Crispr Therapeutics CRSP stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRSP Experts View which covers a lot of information including buying and selling signals
CRSP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


